펜니들 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 바늘 길이별, 치료법별, 지역별, 부문별 예측(2025-2030년)

Pen Needles Market Growth & Trends:

The global pen needles market size is estimated to reach USD 7.8 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Pen Needles Market Report Highlights:

• By product, the standard segment dominated the market in 2024, due to the availability of cost-effective needles as compared to safety needles.
• Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements.
• Amongst the needle lengths, 5 mm-sized pen needles segment held the largest share in 2024, due to its optimal balance of comfort and effectiveness for subcutaneous injections.
• Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length.
• Insulin therapy accounted for the largest market share in 2024, due to rising awareness regarding self-administration of insulin amongst the diabetic patients.
• Europe dominated the pen needles market in 2024, followed by North America owing to the high prevalence of diabetes in the European region.
• Asia Pacific region is anticipated to exhibit the significant CAGR over the forecast period, owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Needle Length
  • 1.2.3. Therapy
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Needle length outlook
  • 2.2.3. Therapy outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pen Needles Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of diabetes
    • 3.2.1.2. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Preference for alternative drug delivery method
    • 3.2.2.2. Lack of skilled professionals
• 3.3. Pen Needles Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pen Needles Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pen Needles Market: Product Movement Analysis
• 4.3. Pen Needles Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Standard Pen Needles
  • 4.5.1. Standard Pen Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Safety Pen Needles
  • 4.6.1. Safety Pen Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pen Needles Market: Needle Length Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pen Needles Market: Needle Length Movement Analysis
• 5.3. Pen Needles Market by Needle Length Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. 4mm
  • 5.5.1. 4mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. 5mm
  • 5.6.1. 5mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. 6mm
  • 5.7.1. 6mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. 8mm
  • 5.8.1. 8mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. 10mm
  • 5.9.1. 10mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. 12mm
  • 5.10.1. 12mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pen Needles Market: Therapy Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pen Needles Market: Therapy Movement Analysis
• 6.3. Pen Needles Market by Therapy Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Insulin
  • 6.5.1. Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Glucagon-Like-Peptide-1
  • 6.6.1. Glucagon-Like-Peptide-1 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Growth Hormone
  • 6.7.1. Growth Hormone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pen Needles Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Pen Needles Market Movement Analysis
• 7.3. Pen Needles Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1 Key Country Dynamics
    • 7.5.7.2 Competitive Scenario
    • 7.5.7.3 Regulatory Framework
    • 7.5.7.4 Reimbursement scenario
    • 7.5.7.5 UK Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1 Key Country Dynamics
    • 7.5.8.2 Competitive Scenario
    • 7.5.8.3 Regulatory Framework
    • 7.5.8.4 Reimbursement scenario
    • 7.5.8.5 Germany Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1 Key Country Dynamics
    • 7.5.9.2 Competitive Scenario
    • 7.5.9.3 Regulatory Framework
    • 7.5.9.4 Reimbursement scenario
    • 7.5.9.5 France Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1 Key Country Dynamics
    • 7.5.10.2 Competitive Scenario
    • 7.5.10.3 Regulatory Framework
    • 7.5.10.4 Reimbursement scenario
    • 7.5.10.5 Italy Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1 Key Country Dynamics
    • 7.5.11.2 Competitive Scenario
    • 7.5.11.3 Regulatory Framework
    • 7.5.11.4 Reimbursement scenario
    • 7.5.11.5 Spain Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1 Key Country Dynamics
    • 7.5.12.2 Competitive Scenario
    • 7.5.12.3 Regulatory Framework
    • 7.5.12.4 Reimbursement scenario
    • 7.5.12.5 Denmark Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1 Key Country Dynamics
    • 7.5.13.2 Competitive Scenario
    • 7.5.13.3 Regulatory Framework
    • 7.5.13.4 Reimbursement scenario
    • 7.5.13.5 Sweden Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1 Key Country Dynamics
    • 7.5.14.2 Competitive Scenario
    • 7.5.14.3 Regulatory Framework
    • 7.5.14.4 Reimbursement scenario
    • 7.5.14.5 Norway Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.15. Asia Pacific
  • 7.5.16. Asia Pacific Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.17. Japan
    • 7.5.17.1 Key Country Dynamics
    • 7.5.17.2 Competitive Scenario
    • 7.5.17.3 Regulatory Framework
    • 7.5.17.4 Reimbursement scenario
    • 7.5.17.5 Japan Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.18. China
    • 7.5.18.1 Key Country Dynamics
    • 7.5.18.2 Competitive Scenario
    • 7.5.18.3 Regulatory Framework
    • 7.5.18.4 Reimbursement scenario
    • 7.5.18.5 China Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.19. India
    • 7.5.19.1 Key Country Dynamics
    • 7.5.19.2 Competitive Scenario
    • 7.5.19.3 Regulatory Framework
    • 7.5.19.4 Reimbursement scenario
    • 7.5.19.5 India Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.20. South Korea
    • 7.5.20.1 Key Country Dynamics
    • 7.5.20.2 Competitive Scenario
    • 7.5.20.3 Regulatory Framework
    • 7.5.20.4 Reimbursement scenario
    • 7.5.20.5 South Korea Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.21. Australia
    • 7.5.21.1 Key Country Dynamics
    • 7.5.21.2 Competitive Scenario
    • 7.5.21.3 Regulatory Framework
    • 7.5.21.4 Reimbursement scenario
    • 7.5.21.5 Australia Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.22. Thailand
    • 7.5.22.1 Key Country Dynamics
    • 7.5.22.2 Competitive Scenario
    • 7.5.22.3 Regulatory Framework
    • 7.5.22.4 Reimbursement scenario
    • 7.5.22.5 Thailand Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.23. Latin America
  • 7.5.24. Latin America Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.25. Brazil
    • 7.5.25.1 Key Country Dynamics
    • 7.5.25.2 Competitive Scenario
    • 7.5.25.3 Regulatory Framework
    • 7.5.25.4 Reimbursement scenario
    • 7.5.25.5 Brazil Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.26. Argentina
    • 7.5.26.1 Key Country Dynamics
    • 7.5.26.2 Competitive Scenario
    • 7.5.26.3 Regulatory Framework
    • 7.5.26.4 Reimbursement scenario
    • 7.5.26.5 Argentina Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.27. Middle East & Africa
  • 7.5.28. Middle East & Africa Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.29. South Africa
    • 7.5.29.1 Key Country Dynamics
    • 7.5.29.2 Competitive Scenario
    • 7.5.29.3 Regulatory Framework
    • 7.5.29.4 Reimbursement scenario
    • 7.5.29.5 South Africa Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.30. Saudi Arabia
    • 7.5.30.1 Key Country Dynamics
    • 7.5.30.2 Competitive Scenario
    • 7.5.30.3 Regulatory Framework
    • 7.5.30.4 Reimbursement scenario
    • 7.5.30.5 Saudi Arabia Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.31. UAE
    • 7.5.31.1 Key Country Dynamics
    • 7.5.31.2 Competitive Scenario
    • 7.5.31.3 Regulatory Framework
    • 7.5.31.4 Reimbursement scenario
    • 7.5.31.5 UAE Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.32. Kuwait
    • 7.5.32.1 Key Country Dynamics
    • 7.5.32.2 Competitive Scenario
    • 7.5.32.3 Regulatory Framework
    • 7.5.32.4 Reimbursement scenario
    • 7.5.32.5 Kuwait Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Novo Nordisk A/S
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. BD
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Terumo Corp.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. . Owen Mumford Ltd.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Ypsomed
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. B. Braun Melsungen AG
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. . HTL-STREFA
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. UltiMed, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Allison Medical, Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Artsana S.p.A.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives